2016

  • In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, Delavallée L, Levescot A, Roga S, Decker P, Girard JP, Herbelin A, Boissier MC, Bessis N. J Immunol. 2016 Sep 1;197(5):1708-19. doi: 10.4049/jimmunol.1502124.
  • Developments with investigational Janus kinase inhibitors for rheumatoid arthritis. Semerano L, Decker P, Clavel G, Boissier MC. Expert Opin Investig Drugs. 2016 Dec;25(12):1355-1359.
  • Personality modulates proportions of CD4+ regulatory and effector T cells in response to socially induced stress in a rodent of wild origin. Rangassamy M, Khaleghparast Athari S, Monclús R, Boissier MC, Bessis N, Rödel HG. Physiol Behav. 2016 Dec 1;167:255-264. doi: 10.1016/j.physbeh.2016.09.016.
  • Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review. Minichiello E, Semerano L, Boissier MC. Joint Bone Spine. 2016 Dec;83(6):625-630. doi: 10.1016/j.jbspin.2016.07.007.
  • Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33. Athari SK, Poirier E, Biton J, Semerano L, Hervé R, Raffaillac A, Lemeiter D, Herbelin A, Girard JP, Caux F, Boissier MC, Bessis N. Arthritis Res Ther. 2016 Jun 18;18(1):143. doi: 10.1186/s13075-016-1042-x.
  • Novel Immunotherapeutic Avenues for Rheumatoid Arthritis. Semerano L, Minichiello E, Bessis N, Boissier MC. Trends Mol Med. 2016 Mar;22(3):214-29. doi: 10.1016/j.molmed. 2016.01.005. Review.
  • Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis. Denys A, Clavel G, Lemeiter D, Schischmanoff O, Boissier MC, Semerano L. J Cell Mol Med. 2016 May;20(5):855-63. doi: 10.1111/jcmm.12790.
  • Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression. Perez J, Dansou B, Hervé R, Levi C, Tamouza H, Vandermeersch S, Demey-Thomas E, Haymann JP, Zafrani L, Klatzmann D, Boissier MC, Letavernier E, Baud L. J Immunol. 2016 Jan 1;196(1):168-81. doi: 10.4049/jimmunol.1500749.
  • Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis. Semerano L, Duvallet E, Belmellat N, Marival N, Schall N, Monteil M, Grouard-Vogel G, Bernier E, Lecouvey M, Hlawaty H, Muller S, Boissier MC, Assier E. Angiogenesis. 2016 Jan;19(1):39-52. doi: 10.1007/s10456-015-9487-0.